Homology Medicines Announces Upcoming Presentations Highligh

- First Preclinical Data Sets Demonstrating Potential to Re-Dose with AAVHSCs and to Identify Genomic Sites with Improved Gene Editing Integration Efficiency - BEDFORD, Mass., May 03, 2023 --... | May 3, 2023

Related Keywords

Oxford Biomedica , Albert Seymour , Cara Mayfield , Brad Smith , American Society Of Gene Cell Therapy , Exchange Commission , Globenewswire Inc , Securities Exchange , Company Contacts , Nasdaq , Homology Medicines Inc , Corporate Communications , Identify Genomic Sites , Improved Gene Editing Integration Efficiency , Cell Therapy , Annual Meeting , Chief Executive Officer , Across Species , Regimen Used , Ongoing Clinical Trials , Nonclinical Support , Gene Therapy Candidate , Therapy Candidate , Metachromatic Leukodystrophy , Across Clades , Neutralizing Antibodies , Homologous Recombination Based Gene , Homology Directed Strand Cross Over Using , Homology Medicines , Securities Act , Securities Exchange Act , Annual Report , Business Officer , Nc Stock Exchange , News , Information , Press Release , Reclinical , Data , Jets , Emonstrating , Potential , O , Ith , Avhscs , End , Identify , Enomic , Sites , Mproved , Gene , Editing , Integration , Efficiency , Bay , 023 Fixx Us4380831077 ,